Medical devices, healthcare technology and the business of care
510(k) clearance · K260884

UNIDRIVE Select System

Karl Storz SE & CO. KG · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONK260884

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on September 1, 2026 for the UNIDRIVE Select System, a 510(k) submitted by Karl Storz SE & CO. KG under number K260884. The application was received March 17, 2026, and the device is classified as a laparoscope for general and plastic surgery under regulation 876.1500, product code GCJ, within the Gastroenterology/Urology review panel. SESE denotes clearance to market, not premarket approval.

The FDA document describes the UNIDRIVE Select System as a motorized surgical system operated with software license UM604. The available excerpts also reference an AC powered battery charger, suction tube and suction canister, but do not establish which of these are the changed or added items, nor the specific predicate device or the scope of any comparison. Indications, clinical performance data and labeling details are not present in the retrieved text and remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 1, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260884
Regulatory pathway
510(k) premarket notification
Product code
GCJ
Decision code
SESE
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Laparoscope, General & Plastic Surgery.

Product code
GCJ
FDA device class
2

FDA decision timeline

  1. K260884 received

    Application receipt date recorded by FDA.

  2. K260884 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GCJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Karl Storz SE & CO. KG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tuttlingen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records